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Magnetosomes are nano-sized magnetic nanoparticles with exquisite properties that can be used in a wide
range of healthcare and biotechnological applications. They are biosynthesised by magnetotactic bacteria
(MTB), such asMagnetospirillum gryphiswaldenseMSR-1 (Mgryph). However, magnetosome bioprocessing
yields low quantities compared to chemical synthesis of magnetic nanoparticles. Therefore, an
understanding of the intracellular metabolites and metabolic networks related to Mgryph growth and
magnetosome formation are vital to unlock the potential of this organism to develop improved
bioprocesses. In this work, we investigated the metabolism of Mgryph using untargeted metabolomics.
Liquid chromatography-mass spectrometry (LC-MS) was performed to profile spent medium samples of
Mgryph cells grown under O2-limited (n ¼ 6) and O2-rich conditions (n ¼ 6) corresponding to
magnetosome- and non-magnetosome producing cells, respectively. Multivariate, univariate and
pathway enrichment analyses were conducted to identify significantly altered metabolites and pathways.
Rigorous metabolite identification was carried out using authentic standards, the Mgryph-specific
metabolite database and MS/MS mzCloud database. PCA and OPLS-DA showed clear separation and
clustering of sample groups with cross-validation values of R2X ¼ 0.76, R2Y ¼ 0.99 and Q2 ¼ 0.98 in
OPLS-DA. As a result, 50 metabolites linked to 45 metabolic pathways were found to be significantly
altered in the tested conditions, including: glycine, serine and threonine; butanoate; alanine, aspartate
and glutamate metabolism; aminoacyl-tRNA biosynthesis and; pyruvate and citric acid cycle (TCA)
metabolisms. Our findings demonstrate the potential of LC-MS to characterise key metabolites in
Mgryph and will contribute to further understanding the metabolic mechanisms that affect Mgryph
growth and magnetosome formation.1. Introduction
Magnetotactic bacteria (MTB) are a diverse group of microor-
ganisms which are able to produce intracellular nano-sized
crystals of magnetite (Fe3O4) or greigite (Fe3S4) bound to
a cytoplasmic membrane and packed in a chain-like structure
namely, the magnetosomes.1 These biosynthesised magnetic
nanoparticles present exquisite properties, such as exhibiting
a narrow size distribution, ferrimagnetism, and high stabilityMaterials and Healthcare Technologies
Nottingham, Nottingham, NG7 2RD, UK.
Tel: +44 (0)115 74 84697
, University of Nottingham, Nottingham,
n University, Birmingham, B4 7ET, UK.
Tel: +44 (0)121 204 4870
ston University, Birmingham, B4 7ET, UK
tion (ESI) available. See DOI:
32560towards self-aggregation,1,2 and they can be functionalised in
vivo using genetic engineering tools.3 Magnetosomes can be
used in a wide range of biotechnological and biomedical
applications, such as cancer therapy, magnetic resonance
agents or bioremediation.2,4–6 However, their real-world appli-
cation is hindered to a large extent by the low availability of such
materials.
Magnetospirillum gryphiswaldense MSR-1 (Mgryph) is an MTB
that can be grown at relatively high cell densities and is capable
of producing up to 4% of its dry cell weight in the form of
magnetosomes.7 Mgryph has been extensively used as an MTB
model organism addressing genetics, physiology and magne-
tosome formation mechanism studies.8 Recently, advances in
Mgryph bioprocessing9–11 and metabolic engineering12 have
resulted in an increase of magnetosome yields, thus, paving the
way for future magnetosome production at a large scale.
However, magnetosome formation occurs under tightly
controlled growth conditions. For example, Mgryph synthesises
magnetosomes in an O2-limited environment as theThis journal is © The Royal Society of Chemistry 2020
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View Article Onlinebiomineralisation of the magnetite is only viable under micro-
aerobic conditions.3 The carbon source and its effect on cell
growth and magnetosome formation have been widely studied
inMgryph.3,11 However, the central carbonmetabolism (CCM) of
Mgryph and the regulation of its metabolic pathways during the
formation of the magnetosome and the cell growth is poorly
understood at the cellular level. CCM is known to provide
biomass precursors and energy through a carbon ux into
different biochemical reactions. Previous studies suggested that
the production of magnetosomes is an energy-dependent
process as the ATPase13 and the magnetosome membrane
protein MamK14 were found to be involved in the ferrous uptake
by the MTB. Moreover, the cyclic AMP (cAMP) receptor protein
(CRP), which is a global transcriptional regulator in prokary-
otes, was found to play an important role in energy metabolism
and in the formation of magnetosomes.15 However, further
studies of the intermediates, such as the uxes of the intracel-
lular metabolites at different stages of the cell growth, and their
complex networks, including CCM, by whichmagnetosomes are
formed, remain unexplored in Mgryph. Such research can
potentially enable unlocking of the mechanism whereby effi-
cient cell growth and magnetosome production can be
optimised.
Metabolomics using liquid chromatography-mass spec-
trometry (LC-MS) has the potential to provide an insight into
cell metabolism and metabolic pathways.16,17 For instance, LC-
MS was successfully used to monitor the intracellular metabo-
lites of Clostridium autoethanogenum during gas fermentation,
which enabled the optimisation of biofuel production using
computational modelling.18 In addition, the growth medium
analysis of bacterial cells using LC-MS provides comprehensive
metabolic information which enables the study of the micro-
environmental changes caused by the microbial activities under
different culture conditions.19 Since the analysis of the extra-
cellular metabolites in a growth medium using LC-MS requires
minimum sample preparation (no complicated cell quenching
and extraction procedures), this technique was used success-
fully to monitor metabolic changes in the growth media ana-
lysed from E. coli cultures investigating the efficient
fermentation of fucose for bio-based products,20 and Clos-
tridium acetobutylicum to study the use of polyketides to regulate
cellular differentiation.21However, to the best of our knowledge,
no LC-MS studies have been performed for the metabolic
characterisation of Mgryph. This technique can be employed to
monitor the CCM and determine the affected pathways linked
to the production of magnetosomes by Mgryph.
In this study, we rst characterised the physiological prop-
erties ofMgryph grown under O2-limited and O2-rich conditions
in shake ask cultures. Then, we applied untargeted metab-
olomics using LC-MS for proling and identication of
metabolites in the growth media. This was done in order to
investigate the signicantly altered metabolites and pathways
in Mgryph. Our ndings indicate that 50 metabolites linked to
45 metabolic pathways were found to be signicantly altered in
the tested conditions. This study paves the way for the appli-
cation of LC-MS-based metabolomics to understand theThis journal is © The Royal Society of Chemistry 2020metabolism of MTB, leading to the development of processes to
achieve enhanced production of magnetosomes.2. Experimental
2.1 Chemicals and reagents
LC-MS grade methanol and acetonitrile were obtained from
Fisher Scientic (Loughborough, UK) and VWR (West Sussex,
UK), respectively. Ammonium carbonate, chemicals and all
analytical standards were obtained from either Sigma-Aldrich
(Gillingham, UK) or Fisher Scientic (Loughborough, UK)
unless otherwise stated. Deionised water was prepared using
a Milli-Q water purication system (Millipore, MA, USA). Five
mixtures of 235 authentic standards were prepared at
a concentration of 20 mM and used for the identication of the
metabolites in the study. The list of the standards is available in
Table S1 in the ESI.†2.2 Strains, growth media and culture conditions of Mgryph
Mgryph MSR-1 was acquired from Deutsche Sammlung von
Mikroorganismen und Zellkulturen GmbH culture collection
(DSMZ, Braunschweig, Germany). Two types of Mgryph cells
were obtained: (1) magnetosome and (2) non-magnetosome
producing cells from microaerobic and aerobic bioreactor
cultures, respectively, carried out under controlled conditions
using a pH-stat fermentation strategy adapted from our
previous study.22 Both cell types were further re-suspended in
2 mL of phosphate-buffered saline (PBS), inoculated into 38 mL
of Flask Standard Medium (FSM) and grown at 30 C in a shaker
incubator at 150 rpm for 48 h. Magnetosome producing cells (n
¼ 6) were grown in airtight O2-limited cultures while non-
magnetosome producing cells (n ¼ 6) were grown in aerobic
cultures. The FSM was composed of 0.1 g L1 yeast extract, 3 g
L1 soybean peptone, 3.5 g L1 potassium L-lactate, 100 mM
iron(III) citrate, 0.34 g L1 NaNO3, 0.1 g L
1 KH2PO4, 0.15 g L
1
MgSO4$7H2O, 5mL L
1 of EDTA-chelated trace elementmixture
and 2.38 g L1 4-(2-hydroxyethyl)piperazine-1-ethane sulfonic
acid (HEPES) buffer in deionized water; adjusted to pH 7.0 prior
to autoclave sterilisation.2.3 Polyhydroxyalkanoates imaging using uorescence
microscopy
Mgryph cells (100 mL) were taken from FSM cultures and stained
with 5 mL of 0.1 mg mL1 of pyrromethene-546 (Pyr-546) in
dimethyl sulfoxide for polyhydroxyalkanoates (PHAs) imaging.
A Zeiss Primo Star iLed microscope (Carl Zeiss Ltd., Cambridge,
UK) tted with a Zeiss AxioCam ERc 5s camera was used. Images
were acquired within 1 min of uorophore incubation and
processed with the aid of Zeiss ZEN Lite 2012 soware in auto
exposure mode. Samples were excited with a Zeiss Led 470 nm
light source and a 515 LP lter was employed for detection of
Pyr-546 uorescence.RSC Adv., 2020, 10, 32548–32560 | 32549
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View Article Online2.4 Measurement of cell concentration and cellular
magnetism
Culture optical densities were recorded at a wavelength of
565 nm (OD565) using an Evolution 300 UV-vis spectrophotom-
eter controlled by Thermo Scientic™ VISIONpro™ soware
(Thermo Fisher Scientic, Hemel Hempstead, UK). Cellular
magnetic response (Cmag) values were determined by OD565
measurements using a purpose-built magnetic measurement
system mounted within the spectrophotometer as described
elsewhere.22 Cmag values greater than “1” indicate the presence
of the magnetic cells.2.5 Transmission electron microscopy
The bacterial samples (2 mL) were drop cast on a graphene oxide
on lacey carbon supported 300 mesh copper grid
(GOLC300Cu50, EM Resolutions, Sheffield, UK) and vacuum-
dried before analysis. Transmission Electron Microscopy
(TEM) images were obtained using a JEM-2100F microscope
(JEOL, Herts, UK) operated at 200 kV equipped with a Gatan
Orius CCD camera (Pleasanton, USA).2.6 Sample preparation for LC-MS
Samples (1 mL) were taken aer 48 h of cultivation and were
immediately centrifuged at 10 000g for 3 min at 4 C. The spent
media were then separated from the cell pellets and kept at
80 C for LC-MS-based metabolite proling. The spent
medium samples of magnetosome (n ¼ 6), non-magnetosome
producing cells (n ¼ 6) of Mgryph and the control FSM (n ¼ 6)
were prepared for LC-MS as follows: an equal volume of the
thawed medium on ice (50 mL) from each culture was added to
an equal volume of methanol (50 mL) (1 : 1 sample : methanol),
vortexed for 30 s, cooled on ice for 2 min, centrifuged at 10 000g
at 4 C for 5min and analysed immediately. Reagent blanks (n¼
3) were prepared using 1 : 1 water : methanol following the
same procedure excluding the sample. For metabolomics
analysis, a sample was prepared by mixing 20 mL from each
sample in the study and used as a pooled QC sample.2.7 Analytical methodologies: LC-MS for metabolite
proling and LC-MS/MS for metabolite identication
LC-MS analysis was performed using a Q-Exactive Plus mass
spectrometer (MS) equipped with Dionex U3000 UHPLC system
(Thermo Fisher Scientic, Hemel Hempstead, UK). Metabolites
in the samples (5 mL, 4 C) were separated on a ZIC-pHILIC
column (4.6  150 mm, 5 mm particle size, Merck SeQuant,
Watford, UK) in which the column wasmaintained at a ow rate
of 300 mL min1 at a temperature of 45 C for 24 min as previ-
ously described.23 The gradient started with 20% A (20 mM
ammonium carbonate in water) and 80% of B (acetonitrile) and
increased to 95% A over 15 min, then the composition was
returned to its initial conditions in 2 min and the column was
re-equilibrated for 7 min. The MS was operated in ESI+ and
ESI switching acquisition modes for LC-MS proling of the
samples and in data-dependent MS/MS (ddMS/MS) for identi-
cation for the analysis of the QC samples. For MS parameters,32550 | RSC Adv., 2020, 10, 32548–32560spray voltage was 4.5 kV (ESI+) and 3.5 (ESI), and capillary
voltage was 20 V (ESI+) and 15 V (ESI). The sheath, auxiliary
and sweep gas ow rates were 40, 5 and 1 (arbitrary unit),
respectively, for both modes. Capillary and heater temperatures
were maintained at 275 and 150 C, respectively. Data were
acquired for the LC-MS proling with a resolution of 70 000
from m/z 70–1050. Top 5 ddMS/MS was performed on the QC
sample (n ¼ 3) at a resolution of 17 500 and a stepped nor-
malised collision energy (NEC) of 20, 30 and 40.
The spent medium samples of the magnetosome, non-
magnetosome producing cells and blank media (FSM, control)
were randomised and analysed in a single LC-MS analytical run
with the mixtures of authentic standards and reagent blanks.
Pooled QC (n ¼ 6) was injected at the beginning of the analysis
to condition the column and aer every 3–5 samples (n ¼ 6) to
check the stability, robustness, repeatability and performance
of the analytical system.2.8 Data analysis and metabolite identication
The acquired raw LC-MS datasets of the samples in the study
were pre-processed for untargeted metabolomics, univariate
analysis and metabolite identication with Compound Discov-
erer 3.1 SP1 soware (Thermo Fisher Scientic, Hemel Hemp-
stead, UK). Principal component analysis (PCA) and orthogonal
partial least squares-discriminant analysis (OPLS-DA) were
performed using Simca P+13 (Umetrics, Umea˚, Sweden). The
imported datasets were mean-centred and Pareto scaled. Cross-
validation using the leave-one-out method was used to evaluate
the robustness of the generated PCA and OPLS-DA by moni-
toring the tness of model (R2X) for PCA, (R2Y) for OPLS-DA and
predictive ability (Q2) values.24 Metabolite identication was
performed using Compound Discoverer 3.1 SP1 soware by
matching accurate masses of the detected peaks with metabo-
lites in Mgryph MSR-1 (MGRY1430440) BioCyc database, the
retention times (RT) of the authentic standards (within 0.25min
shi) and mzCloud fragmentation database. Briey, retention
time range used was 3.2–23.5 min, mass range wasm/z 70–1050,
mass tolerance for peak picking and metabolite identication
was # 5 ppm for precursor and fragment ions, minimum peak
intensity was 1.0  106, intensity tolerance was at 30%, area
max was greater or equal to 3.0  106, maximum retention time
shi was 0.25 min and activation energy tolerance was 5. The
condence in metabolite identication was assigned as level 1–
4 based on the recommendation by the Chemical Analysis
Working Group, Metabolomics Standards Initiative (MSI).25,26 In
this classication, the metabolites identied usingm/z, RT and/
or MS/MS of reference standards were level 1, putatively anno-
tated metabolites using m/z, RT and/or MS/MS from spectral
library and no reference standards were level 2, putatively
characterised metabolite classes were level 3 and unknowns
were classied as level 4.
Variable importance in the projection (VIP) and |p(corr)| of
the OPLS-DA were used to extract the metabolites responsible
for the difference between the spent media of magnetosome
and non-magnetosome producing cells. Student t-test adjusted
with false discovery rate using the Benjamini–HochbergThis journal is © The Royal Society of Chemistry 2020
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View Article Onlineapproach27 for multiple testing problem were performed across
all peak intensities detected in the samples.2.9 Pathway analysis and metabolite network mapping
Pathway analysis, enrichment and network mapping of the
signicantly altered metabolites between magnetosome and
non-magnetosome producing cells were performed using
MetaboAnalyst 4.0.28 The normalised abundances of the
metabolites were Pareto scaled and processed for metabolite
enrichment and pathway analysis while fold changes were used
for KEGG metabolite network mapping.3. Results and discussion
3.1 Comparison of physiological changes of Mgryph grown
under O2-limited and O2-rich culture conditions
To characterise the physiological differences between Mgryph
grown with O2-rich and O2-limited conditions, we used cryo-
stocks from bioreactors using a pH-stat feeding strategy.Fig. 1 Effect of O2 limitation on the physiology of Mgryph. Cultures wer
48 h. (A) OD565 (black bars) and cellular magnetism (Cmag; pale grey bars)
with Pyr-546 and transmission electron micrographs of magnetic (B) an
This journal is © The Royal Society of Chemistry 2020Magnetic and non-magnetic cryostocks were prepared in 5%
DMSO using cells harvested from a bioreactor experiment
grown under microaerobic (pO2 < 1%) and aerobic (pO2 > 5%)
conditions, respectively. Magnetic (n ¼ 6) and non-magnetic (n
¼ 6) cryostocks were inoculated into fresh FSM (control) and
grown in O2-limited and O2-rich conditions (free air exchange),
respectively, at 30 C on a shaker incubator (150 rpm). Both
cultures had headspace volumes of 20% and OD565 and Cmag
were measured aer 48 h. PHAs and magnetosome contents
were also measured (Fig. 1). Cells grown under O2-rich condi-
tions grew better than O2-limited conditions. It was conrmed
that cells grown under O2-rich conditions were not magnetic
(Cmag ¼ 1), whereas cells grown under O2-limited conditions
were magnetic (Cmag ¼ 1.82) (Fig. 1A). Strong Pyr-546 uores-
cence and electron microscopy images indicated the presence
of large quantities of PHAs in both cultures (Fig. 1B and C). TEM
analysis conrmed the presence and absence of magnetosome
chains in the O2-limited and O2-rich cultures, respectively.
These results are in agreement with ndings from our previous
studies:29 using a 20% headspace volume allows relatively highe grown under O2-limited and O2-rich conditions and characterised at
. Error bars are standard deviation (n ¼ 6). Fluorescence of cells stained
d non-magnetic (C) cells.
RSC Adv., 2020, 10, 32548–32560 | 32551
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View Article Onlinegrowth under free air exchange conditions, whereas it main-
tains the magnetic properties of Mgryph in shake ask
cultures.29 The presence of PHAs has been previously reported
and might be due to the redirection of nutrients and energy
competition between PHAs and magnetosome formation. In
contrast, magnetosome formation is inhibited under aerobic
conditions.30
3.2 Performance of LC-MS for untargeted metabolomics
The performance of the LC-MS-basedmetabolite proling of the
culture medium samples of magnetosome and non-
magnetosome producing cells, and FSM (control medium
sample) was assessed using univariate andmultivariate analysis
of all the detected peaks in the samples. The LC-MS datasets
generated 2556 peaks in which the variability based on the use
of relative standard deviations (RSDs) across the average peak
areas was less than 30% for 93.3% of all peaks present in the
QC. The variability in the QC was lower than the recommended
threshold of RSD < 30% for at least 70% of all peaks for
metabolomics analysis.31 PCA was also used to assess the
analytical performance of the method.32,33 The pooled QCs were
closely clustered towards the centre of the PCA scores plot
(Fig. 2). These results demonstrate satisfactory instrumental
stability and validate the LC-MS analytical performance for
untargeted metabolomics.
3.3 Data analysis
The mass ion pairs (RT, m/z) from the dataset generated in this
study were exported with their normalised abundances for
multivariate analysis in which PCA and OPLS-DA were used for
modelling the differences and similarities between samples.
PCA was used to give an unbiased overview of any possible
trends and clusters within the sample datasets. PCA-class
analysis was rst performed to evaluate the similarity of
samples within each class. Tight clusters with no signicantFig. 2 PCA scores plot of FSM (flask standard media, control) and spent
(O2-limited) cells analysed with LC-MS (cross validation: R
2X ¼ 0.81 and
32552 | RSC Adv., 2020, 10, 32548–32560differences were observed within each class, indicated by the
poor PCA-class Q2 values (data not shown). This result
demonstrates that the experimental setup, including the growth
of microorganism, sample preparation and the analytical run,
were carefully carried out, evidencing no outliers and adequate
similarities within each class in the analysis.
Clear clustering and separation were observed in the meta-
bolic proles of the spent media of magnetosome and non-
magnetosome producing cells, and FSM controls in both PCA
and OPLS-DA scores plots (Fig. 2 and 3A). As can be seen in
Fig. 3B, a further comparative OPLS-DA of the spent media of
magnetosome and non-magnetosome producing cells showed
that they were clearly separated and clustered, indicating that
the metabolic prole is more distinct from one class into
another. Cross-validation of this OPLS-DA was excellent with
a cumulative R2X of 0.76, R2Y of 0.99 and Q2 of 0.98; these values
indicate that the models are less likely to be overtted as they
are higher than the recommended values of 0.50 of R2X, R2Y
and Q2 for a robust model.243.4 Feature selection and comparison of the signicantly
altered metabolites related to the presence of the
magnetosomes
The 2556 metabolite features detected in the spent media of
magnetosome compared to non-magnetosome producing cells
(Fig. 4A) were submitted for metabolite identication using
Compound Discoverer 3.1 SP1. The m/z, RT and/or MS/MS of
these features were interrogated against the specic BioCyc
database of Mgryph, the retention times (RT) of 235 authentic
standards and the mzCloud fragmentation database. 423
metabolites were identied in which only 137 metabolites were
reported with high condence in identication (i.e. Level 1 and
2 only) based on MSI levels of identication25,26 as detailed
earlier (Fig. 4B, Table S2 in the ESI†).media of non-magnetosome (O2-rich) and magnetosome-producing
Q2 ¼ 0.61).
This journal is © The Royal Society of Chemistry 2020
Fig. 3 OPLS-DA scores plots of the spent media of magnetosome (O2-limited), non-magnetosome producing (O2-rich) cells and FSM controls
analysed with LC-MS (cross-validation: (A) R2X ¼ 0.83, R2Y ¼ 0.99 and Q2 ¼ 0.96; (B) R2X ¼ 0.76, R2Y ¼ 0.99 and Q2 ¼ 0.98).
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View Article OnlineThe signicantly altered metabolites in the samples were
selected using both multivariate (OPLS-DA) and univariate
analysis (adjusted p-values). VIP and |p(corr)| of the OPLS-DA
were used to extract the metabolites relevant to the separation
of samples in the model. VIP scores estimate the importance of
each variable in the projection used in OPLS-DA and is oen
used for variable selection, while |p(corr)| reects the reliability
of each VIP score in the model.34 Metabolites with adjusted p-
value < 0.05, VIP > 1.0 and |p(corr)| > 0.4 were considered
signicantly altered metabolites (Fig. 4B). As a result, 50
metabolites, including amino acids, organic acids, energy
molecules and nucleotides, were identied as signicantly
altered metabolites in the magnetosome- compared to non-
magnetosome-producing cells. Fig. 5 shows a means of direct
comparison of the levels of these metabolites; the full list of the
key metabolites can be seen in Table S3 in the ESI.†
The level of AMP, lactate, pyruvate, acetoin, crotonate,
pepicolate, trehalose and guanine were found to be high in the
samples of magnetosome-producing cells compared to non-This journal is © The Royal Society of Chemistry 2020magnetosome producing cells (Table 1). This indicates that
these metabolites were either excreted byMgryph under the O2-
limited growth conditions or, if already present in the growth
media, they were consumed at a slower rate compared to the
O2-rich cultures. The presence of higher level of lactate in the
O2-limited cultures compared to O2-rich cultures is expected
as it is the major carbon source component in FSM. The O2-
limited cultures showed lower biomass than the O2-rich ones
(Fig. 1A), hence, lower consumption of lactate. It is known that
there is a correlation between Mgryph growth and lactate
consumption.22 On the other hand, the presence of acetoin
could be related to its secretion under microaerobic growth
conditions and this has been previously described to occur in
Bacillus subtilis35 grown under microaerobic conditions. The
accumulation of AMP and pyruvate in the spent media of
magnetosome-producing cells may suggest that lactate could
be converted into pyruvate via lactate dehydrogenase and
subsequently acetoin formation occurred via the pyruvate
route.36 Our results suggest that this may act as an alternativeRSC Adv., 2020, 10, 32548–32560 | 32553
Fig. 4 Summary of the detected features, metabolite identification and pathway analysis of the significantly altered metabolites in the spent
media of magnetosome compared to non-magnetosome producing cells. (A) Venn diagram presenting the common and the significantly
changed features detected in the spent media samples, (B) pie-chart showing the significantly changed and the common number of identified
metabolites (Level 1 and 2), putatively identified metabolites (Level 3 and 4) and the unidentified metabolite features between the two sets of
samples; and (C) pathway analysis: the top pathways were ranked by the gamma-adjusted p-values for permutation per pathway (y-axis) and the
total number of hits per pathway (x-axis). Colour graduated fromwhite to yellow, orange and red, circle size (large > small) as well as the values of
both x and y increase represents the degree of significance.
32554 | RSC Adv., 2020, 10, 32548–32560 This journal is © The Royal Society of Chemistry 2020
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Fig. 5 Relative levels expressed as peak area (arbitrary units) of significantly altered metabolites in the spent media of Mgryph grown on O2-
limited cultures (n ¼ 6, magnetosome producing cells) compared to O2-rich cultures (n ¼ 6, non-magnetosome producing cells).
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View Article Onlineenergy and respiratory route during O2-limited growth of
Mgryph. In addition, pepicolate was also found to serve as an
osmoprotector and support the growth of E. coli underThis journal is © The Royal Society of Chemistry 2020stressed conditions37 which may signal that Mgryph upregu-
lated pepicolate to overcome its O2-limited growth. This is
further evident by the accumulation of trehalose in theRSC Adv., 2020, 10, 32548–32560 | 32555
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View Article Onlinesamples of magnetosome producing cells as endogenous
trehalose was found to play an important role as an osmo- and
stress-protector in E. coli.38 For further understanding of the
metabolic changes in Mgryph during the formation of the
magnetosomes, the list of signicant metabolites was
submitted for pathway analysis.
3.5 Pathway analysis and metabolite network mapping
The signicantly changed metabolites identied by comparing
the magnetosome and non-magnetosome producing Mgryph
cells were submitted for pathway analysis and network
mapping using MetaboAnalyst 4.0.28 More than 40 metabolic
pathways were found signicantly affected in the magneto-
some compared to non-magnetosome producing cells (Table
S4 in the ESI†) in which glycine, serine and threonine; buta-
noate; alanine, aspartate and glutamate; aminoacyl-tRNA
biosynthesis; and pyruvate and TCA metabolisms were
highly affected (Fig. 4C, Table 1). Pathway network mapping in
Fig. S1 in the ESI† highlighted the most signicantly altered
metabolite interactions. The map depicts interacting metab-
olites across the metabolic pathways identied through
specic base-pair alignment. As can be observed in Fig. S1 in
the ESI,† L-glutamic acid, pyruvic acid and adenosine mono-
phosphate are the key metabolites showing the highest
number of metabolite interactions across the metabolic
networks.
3.6 The magnetosome and the amino acid metabolism
Amino acids are key carbon and energy sources for the growth
of magnetotactic bacteria.22 They are essential for the growth of
Mgryph and usually supplied in the culture using yeast extract
which are rich in amino acids. Previous works showed that
Mgryph was not be able to sustain growth above 1.5 OD565 when
yeast extract was not included in the culture (not published).
Such growth under limited amino acid source was approxi-
mately 10-fold lower than the highest biomass concentration
reached in Mgryph.22 The levels of glutamine, ornithine, hypo-
xanthine, tryptophan, serine, phenylalanine, glycine, gluta-
mate, 2-oxoglutarate and aspartate were found lower in the
magnetosome producing cells compared to fresh media (FSM)
(Fig. 6, Table S2 in the ESI†) indicating that these amino acids
and their metabolites were signicantly utilised during micro-
aerobic growth of Mgryph. FSM contains large quantities of
yeast extract and peptone, as detailed in the experimental
section, necessary for the growth of Mgryph. Among all amino
acids present in FSM, glutamate appeared to be slightly utilised
in O2-rich growth conditions whilst it was heavily consumed
under O2-limited conditions (Fig. 6, an enlarged version of the
pathway map is also available in Fig. S2 in the ESI†), hence
glutamate utilisation might be potentially linked to the forma-
tion of magnetosomes.
To further understand the decrease of amino acids in the O2-
limited growth conditions in comparison to fresh FSM, it is
necessary to take into account the proteome associated to
magnetosomes and their formation: the conserved genomic
magnetosome island (MAI) in Mgryph comprises 28 genes andRSC Adv., 2020, 10, 32548–32560 | 32557
Fig. 6 Pathway mapping of metabolites detected in the spent medium samples of non-magnetosome (NM), magnetosome (M) producing
Mgryph cells and control FSM. Green circle indicates that the metabolite was detected in the samples while the bar graph shows the relative
abundance of metabolites expressed as peak areas (arbitrary units).
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View Article Onlinetheir associated proteins which are involved in the magneto-
some formation.8,39 This cellular machinery is “switched on”
under microaerobic conditions.3 Therefore, lower levels of the
amino acids, listed above, may indicate that these were utilised32558 | RSC Adv., 2020, 10, 32548–32560in the anabolic metabolism and synthesis of magnetosome-
related proteins for structural or enzymatic purposes. Interest-
ingly, it has been previously reported that aspartate, glutamate,
proline and serine were the only amino acids signicantlyThis journal is © The Royal Society of Chemistry 2020
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View Article Onlineutilised by 3-proteobacteria Campylobacter jejuni during micro-
aerobic growth.40 Also, the authors reported that the growth of
an aspartase (aspA) mutant of Campylobacter jejuni (unable to
utilise any amino acid except serine) and a Cj0762c (aspB)
mutant (unable to utilise glutamate), were severely impaired.
Recently, microaerobic growth conditions were found to upre-
gulate amino acid synthesis genes in E. coli.41 Our ndings,
therefore, may indicate that the glycine, serine and threonine,
and alanine, aspartate and glutamate metabolisms might be
linked to the enhanced utilisation of these amino acids by
Mgryph under O2-limited growth conditions where magneto-
somes were formed.
3.7 Protein biosynthesis in Mgryph
Aminoacyl-tRNAs are substrates for translation and are pivotal
in determining how the genetic code is interpreted as amino
acids, thus playing an important role in protein synthesis.42
Aminoacyl-tRNA biosynthesis pathways were signicantly
enhanced in the magnetosome producing culture, suggesting
that they may be related to the biosynthesis of some proteins
involved in magnetosome formation. These proteins may
include those associated with the complex enzymatic and
structural machinery in the iron biomineralisation and the
formation of the magnetosome membrane which involves
approximately 30 genes.43
3.8 Butyrate metabolism in Mgryph
Butanoate (butyrate) metabolism was signicantly altered
under O2-limited conditions in comparison to O2-rich condi-
tions (Fig. 4C) and describes the metabolic fate of a number of
short chain fatty acids/alcohols. Butanoate metabolism is
linked to the formation of hydroxybutyrate, butyrate, acetone,
succinate and crotonate. The butanoate metabolism is typically
active in a variety of microorganisms that grow under micro-
aerobic or anaerobic conditions, such as the obligate anaerobe
Clostridium butyricum44 or lactic acid bacteria.45 As shown in
Fig. 1, both cultures grown under O2-limited and O2-rich
conditions accumulated large aggregates of PHAs consistent
with previous studies in which limiting N2 and O2 under carbon
excess resulted in high-level accumulation of PHAs in different
bacteria species.46,47 Similar behaviour was also observed in our
previous studies,29 whereby the relative content of PHAs
decreased in microaerobic cultures aer 48 h suggesting that
Mgryph utilised PHAs as substrate. Therefore, the signicant
increase in the butanoate metabolism may indicate that PHAs
were signicantly utilised in the O2-limited cultures whereas the
O2-rich cultures showed lower metabolism by this route.
4. Conclusion
In this study, metabolic characterisation ofMgryph spent media
has been performed in magnetosome and non-magnetosome
producing conditions using LC-MS. This led to the identica-
tion of differentially regulated metabolites in more than 40
metabolic pathways. Our ndings indicate that these signicant
metabolic changes are possibly related to the energy andThis journal is © The Royal Society of Chemistry 2020anabolic metabolism necessary for the growth, the degradation
of PHAs and the synthesis of proteins involved in the formation
of magnetosomes. This study will play a critical role in
improving the understanding of the underlying metabolic
mechanisms in Mgryph. Combined with stable isotope assisted
approaches,18,48,49 this study can be extended to quantify the
intracellular metabolite uxes in specic stages of Mgryph
growth, thus contributing to the further understanding of the
metabolic mechanisms that affect the cell growth and the
magnetosomes formation. In the long term, we envisage that
the signicant improvement of both, Mgryph growth and mag-
netosome production will depend to a large extend, in the
application and combination of “omics” technologies along
with high-yield bioprocessing strategies. This combination will
ultimately accelerate the development of magnetosome-based
products in a wide range of biotechnology and nanomedicine,
such as drug delivery, magnetic hyperthermia and diagnostic
applications.
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